None of those issues are really at a crisis point. No single issue is crying out to be fixed.

249

It's not just an issue of revenue source, it's an issue of good management.

232

There's no reason in my opinion not to give bigger doses. The harm is minimal if anything, and the benefit is potentially more.

200